ENTRY       D03651                      Drug
NAME        Darbepoetin alfa (USAN/INN);
            Darbepoetin alfa (genetical recombination) (JAN);
            Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 1] (JAN);
            Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 2] (JAN);
            Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 3] (JAN);
            Aranesp (TN)
PRODUCT     ARANESP (Amgen)
FORMULA     C800H1300N228O24S5
EXACT_MASS  14646.6117
MOL_WEIGHT  14656.7202
SEQUENCE    PPRLICDSR VLERYLLEAK EAENITTGCN ETCSLNENIT VPDTKVNFYA WKRMEVGQQA
            VEVWQGLALL SEAVLRGQAL LVNSSQVNET LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS
            PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGDR
  TYPE      Peptide
REMARK      Therapeutic category: 3999
            ATC code: B03XA02
            Product: D03651<JP/US>
EFFICACY    Anti-anemic, Erythropoietin receptor agonist
  DISEASE   Anemia due to chronic kidney disease [DS:H01642]
TARGET      EPOR [HSA:2057] [KO:K05079]
  PATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction
            hsa04630(2057)  JAK-STAT signaling pathway
            hsa04640(2057)  Hematopoietic cell lineage
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03X OTHER ANTIANEMIC PREPARATIONS
                B03XA Other antianemic preparations
                 B03XA02 Darbepoetin alfa
                  D03651  Darbepoetin alfa (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Blood Products and Modifiers, Other
               Erythropoietins
                Darbepoetin Alfa
                 D03651  Darbepoetin alfa (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D03651  Darbepoetin alfa (USAN/INN); Darbepoetin alfa (genetical recombination) (JAN); Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 1] (JAN); Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 2] (JAN); Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 3] (JAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                EPOR
                 D03651  Darbepoetin alfa (USAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03651
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03651
DBLINKS     CAS: 209810-58-2
            PubChem: 17397749
///
